1Department of Clinical Research and Development, Fisons Pharmaceuticals, Rochester, New York 14603.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
NONMEM modeling of extended-release pseudoephedrine pharmacokinetics revealed it provides more meaningful estimates than traditional methods. This approach offers enhanced insights into residual error, bioinequivalence, and dose-dumping, even with abundant data.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: